Objective: To investigate the lifestyle, environmental, and clinical determinants that influence the onset and progression of urological cancer (e.g., renal cell carcinoma, bladder cancer) and nephrology-related diseases, and to understand how these factors interact with each other.
Data Source: Utilize comprehensive datasets from the UK Biobank, including information on participants’ lifestyle factors, environmental exposures, clinical history, imaging data, and biomarker profiles.
Methodology:
Epidemiological Analysis: Assess the associations between lifestyle factors (e.g., physical activity, diet), environmental exposures (e.g., pollution, occupational hazards), and clinical indicators (e.g., blood pressure, renal function) with disease risk.
Statistical Modeling: Employ advanced statistical techniques and machine learning algorithms to identify significant predictors and interactions among the determinants.
Biomarker Evaluation: Analyze blood and imaging biomarkers to identify potential early indicators of disease progression and prioritize therapeutic targets.
Expected Outcomes:
Identification of key risk factors contributing to urological cancer and nephrology-related diseases.
Understanding of the interplay between lifestyle, environmental, and clinical factors in influencing disease progression.
Development of evidence-based strategies for early detection, prevention, and personalized therapeutic approaches.
Impact: The findings will guide the design of targeted interventions and inform public health strategies, ultimately aiming to reduce the incidence and improve the management of these diseases.